openPR Logo
Press release

Impact of COVID-19 on the Gluten-free Products Market Growth & Global Forecast to 2025

12-08-2021 09:50 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Markets and Markets

The global gluten-free products market size is estimated to account for nearly USD 5.6 billion in 2020 and projected to grow at a CAGR of 8.1%, to reach nearly USD 8.3 billion by 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=738

The gluten-free products market is driven by factors such as increased diagnosis of celiac diseases and rising adoption for special dietary lifestyles & free form food products. Also, increasing availability of gluten-free products in organized retails is expected to propel the growth of this market in the coming years. However, high cost of gluten-free products compare to conventional gluten-containing products is hampering the market growth.

“Impact of COVID-19 on the current market size and forecast.”

The COVID-19 pandemic is projected to have a moderate and unfavorable impact on the global gluten-free products market. Due to the restricted supply chain activities, manufacturers are not able to procure the raw material and manufacture goods to cater to the demand. Additionally, due to government initiatives such as lockdowns, manufacturing plants were also at a standstill due to the limited workforce available. Global companies are facing challenges in importing and exporting the end products, owing to the limited international trading activities.

All these factors cumulatively have impacted the entire supply chain, thereby impacting the market adversely. However, post-pandemic, the market for gluten-free products is projected to witness an optimistic growth trend, owing to the rise in consumers preferring gluten-free and other free-from foods, as a result of a shift in the consumption lifestyles towards healthier eating. Thus, the market is expected to be at a standstill until the fourth quarter of 2020.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=738

Key players in this market are The Kraft Heinz Company (US), The Hain Celestial Group Inc (US), General Mills (US), Kellogg’s Company (US), ConAgra Brands Inc (US), Hero AG (Switzerland), Barilla G.E.R Fratelli S.P.A (Italy), Quinoa Corporation (US), Freedom Foods Group Limited (Australia), Koninklijke Wessanen N.V (Netherlands), Raisio PLC (Finland), Dr Schär AG/SPA (Italy), Enjoy Life Foods (US), Farmo S.P.A. (Italy), Big OZ (UK), Alara Wholefoods Ltd (UK), Norside Foods Ltd (UK), Warburtons (UK), Silly Yaks (Australia), Seitz Glutenfrei GMBH (Germany), Bob’s Red Mill (US), Kelkin Ltd (Ireland), Amy’s Foods (US), Golden West Specialty Foods (US), and Prima Foods (UK).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Impact of COVID-19 on the Gluten-free Products Market Growth & Global Forecast to 2025 here

News-ID: 2489454 • Views:

More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analysis by 2028
Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624 These fertilizers are prized for their ability
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% from 2024 to 2029
Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%. Download PDF Brochure:
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are